Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01881347 · ClinicalTrials.gov registry record · NA
Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT01881347 is a NA study that has completed, run by Boston University. The registered enrollment target is 54 participants.
The verdict
NCT01881347, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The present study is designed to test the hypothesis that resveratrol supplementation will improve the function of the endothelium in patients with type 2 diabetes mellitus. The function of the endothelium will be tested with a non-invasive technique that uses ultrasound to measure the amount of dilation that occurs in the brachial artery following 5-minute cuff occlusion. To help us understand potential mechanisms of benefit, we will also collect blood, urine, and cell samples and test the effects of treatment on protein expression, nitric oxide production, and function of mitochondria.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Resveratrol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2013-01-01 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01881347
The ClinicalTrials.gov registry entry for NCT01881347 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01881347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01881347 about?
NCT01881347 is a clinical study titled "Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus". The present study is designed to test the hypothesis that resveratrol supplementation will improve the function of the endothelium in patients with type 2 diabetes mellitus. The function of the endothelium will be tested with a non-invasive technique that uses ultrasound to measure the amount of di...
What is the current status of trial NCT01881347?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2013-01-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01881347?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Resveratrol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01881347?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.